Acadia Trust’s Pfizer PFE Stock Holding History

Acadia Trust’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$474K	Sell	14,737 -53	-0.4%	-$1.77K	0.14%	57
2016 Q2	$494K	Buy	14,790 +71	+0.5%	+$2.27K	0.15%	55
2016 Q1	$414K	Hold	14,719	–	–	0.13%	59
2015 Q4	$451K	Sell	14,719 -397	-3%	-$12.5K	0.15%	60
2015 Q3	$451K	Buy	15,116 +1,415	+10%	+$45.4K	0.16%	55
2015 Q2	$436K	Buy	13,701 +698	+5%	+$22.7K	0.16%	53
2015 Q1	$429K	Buy	13,003 +31	+0.2%	+$986	0.15%	59
2014 Q4	$384K	Hold	12,972	–	–	0.13%	65
2014 Q3	$364K	Sell	12,972 -1,797	-12%	-$50.4K	0.13%	61
2014 Q2	$416K	Buy	14,769 +171	+1%	+$4.87K	0.15%	53
2014 Q1	$445K	Buy	14,598 +968	+7%	+$28.9K	0.17%	46
2013 Q4	$397K	Sell	13,630 -346	-2%	-$10.1K	0.16%	52
2013 Q3	$381K	Sell	13,976 -16	-0.1%	-$435	0.16%	50
2013 Q2	$372K	Buy	+13,992	New	+$387K	0.17%	47

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Acadia Trust's PFE Position: Q3 2016 in Review

Acadia Trust reduced its Pfizer (PFE) stake by 0.36% in Q3 2016, selling an estimated $1.77K and leaving 14,737 shares worth $474K. The position accounts for 0.14% of the portfolio, ranked #57.

Acadia Trust first reported a position in PFE in Q2 2013 and has held it in 14 quarters since. The position peaked at $494K in Q2 2016. 1,962 funds tracked by Wall St. Rank hold PFE as of Q3 2016.

Acadia Trust held 14,737 shares of Pfizer worth $474K as of Q3 2016.
Acadia Trust sold 53 Pfizer shares in Q3 2016, an estimated $1.77K.
Pfizer made up 0.14% of Acadia Trust's portfolio in Q3 2016, its #57 holding.
Acadia Trust first reported a position in Pfizer in Q2 2013 and has held it in 14 quarters since.
Acadia Trust's Pfizer position peaked at $494K in Q2 2016.
1,962 funds tracked by Wall St. Rank held Pfizer as of Q3 2016.

Based on Acadia Trust's 13F filing for Q3 2016, filed 15 Nov 2016.